Outside narrow, documented medical need, compounded versions of these drugs are no longer a lawful option, and FDA has logged hundreds of adverse event reports, some requiring hospitalization, tied to dosing errors from patients measuring their own doses out of compounded vials
Omzo GLP-1 Review Verdict (June 2026): Final Assessment for Buyers Ready to Decide Quick Answer: Omzo is a structurally sound, cash-pay telehealth platform with transparent Terms, a three-entity clinical-platform-pharmacy model, and strong compounded medication disclosures
Current studies are still largely in the preclinical or early clinical phases, and larger trials involving human subjects are necessary to confirm the safety and efficacy of these drugs for addiction treatment
Most cases improve with simple diet and lifestyle changes
By 2024, Ozempic had surpassed Trulicity, also approved for type 2 diabetes (not obesity) to make up the largest share of GLP-1 prescriptions and spending (39% in 2024)
Our program combines these medications with medical monitoring, lifestyle guidance, and ongoing support to help you reach and maintain your goals